Cyclosporine ophthalmic solution is a prescription medication used to manage chronic dry eye disease by increasing the production of natural tears. It works by reducing inflammation in the tear-producing glands of the eyes, helping restore tear production in individuals whose tear production is presumed to be suppressed due to ocular inflammation.
This medication is typically instilled into each eye twice a day, about 12 hours apart. While some patients may begin to see improvements in symptoms after 1 month of consistent use, it may take 3 to 6 months for noticeable improvement in tear production.
Cyclosporine is not a lubricant drop and must be used exactly as prescribed to be effective.
How to Use:
Wash hands before handling the bottle
Do not touch the dropper tip to any surface, including the eye
Keep eyes closed for 1 to 2 minutes after instilling
Warnings:
Contact lenses must be removed before using cyclosporine
Wait at least 15 minutes before inserting contact lenses or using other eye drops
May cause temporary burning or stinging upon application
Use only under the direction of a healthcare provider
This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.